VA Peg-Intron registry
Schering-Plough's Peg-Intron (peginterferon alfa-2b) patient registration program will last six to 12 months, Department of Veterans Affairs estimates. VA has established its own registration program, which does not include patient-specific data, because it objected to the amount of information Schering's program was collecting 1("The Pink Sheet" Nov. 5, 2001, p. 20)...
You may also be interested in...
Schering-Plough is implementing a prescription tracking program for PEG-Intron to ensure that existing patients will have adequate supply of peginterferon alfa-2b
Illumina announced on 21 September it will buy back Grail, which is planning to commercialize its multi-cancer early detection blood test Galleri in 2021. See what Illumina’s CEO Francis deSouza said about it here.
Yes, Gottlieb’s in there twice; things get complicated when an agency starts to lose credibility.